Matthew Hamilton Rosenberg’s Boston Scientific BSX Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.9K	Sell	1,544 -259	-14%	-$14.1K	0.01%	405
2026 Q1	$113K	Sell	1,803 -113	-6%	-$9.04K	0.02%	305
2025 Q4	$183K	Buy	1,916 +53	+3%	+$5.2K	0.04%	223
2025 Q3	$182K	Hold	1,863	–	–	0.04%	224
2025 Q2	$200K	Hold	1,863	–	–	0.05%	207
2025 Q1	$188K	Buy	1,863 +43	+2%	+$4.33K	0.05%	195
2024 Q4	$163K	Buy	1,820 +248	+16%	+$21.8K	0.04%	215
2024 Q3	$132K	Hold	1,572	–	–	0.03%	265
2024 Q2	$120K	Hold	1,572	–	–	0.04%	255
2024 Q1	$107K	Hold	1,572	–	–	0.03%	304
2023 Q4	$90.9K	Hold	1,572	–	–	0.03%	326
2023 Q3	$83K	Hold	1,572	–	–	0.03%	326
2023 Q2	$85K	Hold	1,572	–	–	0.03%	327
2023 Q1	$78.6K	Hold	1,572	–	–	0.03%	360
2022 Q4	$72.7K	Hold	1,572	–	–	0.02%	373
2022 Q3	$61K	Buy	1,572 +30	+2%	+$1.2K	0.02%	388
2022 Q2	$59K	Buy	1,542 +242	+19%	+$9.85K	0.02%	410
2022 Q1	$58K	Hold	1,300	–	–	0.02%	424
2021 Q4	$55K	Hold	1,300	–	–	0.02%	403
2021 Q3	$56K	Hold	1,300	–	–	0.02%	372
2021 Q2	$56K	Hold	1,300	–	–	0.03%	343
2021 Q1	$50K	Hold	1,300	–	–	0.03%	348
2020 Q4	$47K	Hold	1,300	–	–	0.03%	335
2020 Q3	$50K	Hold	1,300	–	–	0.04%	310
2020 Q2	$46K	Hold	1,300	–	–	0.04%	318
2020 Q1	$43K	Buy	+1,300	New	+$50.8K	0.04%	277

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Matthew Hamilton Rosenberg's BSX Position: Q2 2026 in Review

Matthew Hamilton Rosenberg reduced its Boston Scientific (BSX) stake by 14% in Q2 2026, selling an estimated $14.1K and leaving 1,544 shares worth $65.9K. The position accounts for 0.01% of the portfolio, ranked #405.

Matthew Hamilton Rosenberg first reported a position in BSX in Q1 2020 and has held it in 26 quarters since. The position peaked at $200K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Matthew Hamilton Rosenberg held 1,544 shares of Boston Scientific worth $65.9K as of Q2 2026.
Matthew Hamilton Rosenberg sold 259 Boston Scientific shares in Q2 2026, an estimated $14.1K.
Boston Scientific made up 0.01% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #405 holding.
Matthew Hamilton Rosenberg first reported a position in Boston Scientific in Q1 2020 and has held it in 26 quarters since.
Matthew Hamilton Rosenberg's Boston Scientific position peaked at $200K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.